QPS' Story: Since its inception, QPS has been assisting pharmaceutical, biotechnology and medical device companies with their drug development efforts by providing a full range of DMPK, Toxicology, Bioanalysis, Translational Medicine, Early Phase Clinical and Phase II - IV Clinical Research services. The LC-MS group's expertise lies in the quantitation of small molecules, oligonucleotides, peptides, proteins, and metabolite biomarkers by various mass spectrometric (LC-MS/(HR)MS, and hybrid/immunoaffinity mass spec) techniques.